Cargando…

Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study

OBJECTIVES: To understand stakeholders’ perceptions of the access barriers to quality-assured diagnostics and medicines for leishmaniasis in the high-burden region of eastern Africa, and to identify key bottlenecks to improve the supply of commodities for neglected tropical diseases. DESIGN: Desk re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sunyoto, Temmy, Potet, Julien, den Boer, Margriet, Ritmeijer, Koert, Postigo, Jose A R, Ravinetto, Raffaella, Alves, Fabiana, Picado, Albert, Boelaert, Marleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Qualitative Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549606/ https://www.ncbi.nlm.nih.gov/pubmed/31152044 http://dx.doi.org/10.1136/bmjopen-2019-029141

Ejemplares similares

Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-Saharan Africa—A systematic review
por: Sunyoto, Temmy, et al.
Publicado: (2018)

Visceral leishmaniasis in Somalia: A review of epidemiology and access to care
por: Sunyoto, Temmy, et al.
Publicado: (2017)

Why miltefosine—a life-saving drug for leishmaniasis—is unavailable to people who need it the most
por: Sunyoto, Temmy, et al.
Publicado: (2018)

“Kala-Azar is a Dishonest Disease”: Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan
por: Sunyoto, Temmy, et al.
Publicado: (2018)

Visceral Leishmaniasis and HIV Coinfection in East Africa
por: Diro, Ermias, et al.
Publicado: (2014)

Control of visceral leishmaniasis in East Africa: fragile progress, new threats
por: Dahl, Elin Hoffmann, et al.
Publicado: (2021)

Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease
por: Boelaert, Marleen, et al.
Publicado: (2014)

Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus–Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial
por: Diro, Ermias, et al.
Publicado: (2018)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study
por: Diro, Ermias, et al.
Publicado: (2015)

The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018
por: Naylor-Leyland, Gabriel, et al.
Publicado: (2022)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia – A review and meta-analysis
por: Pijpers, Joyce, et al.
Publicado: (2019)

Snakebite envenoming in humanitarian crises and migration: A scoping review and the Médecins Sans Frontières experience
por: Alcoba, Gabriel, et al.
Publicado: (2021)

Burden of Visceral Leishmaniasis in Villages of Eastern Gedaref State, Sudan: An Exhaustive Cross-Sectional Survey
por: Mueller, Yolanda Kathrin, et al.
Publicado: (2012)

Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India
por: Mahajan, Raman, et al.
Publicado: (2015)

A Screen-and-Treat Strategy Targeting Visceral Leishmaniasis in HIV-Infected Individuals in Endemic East African Countries: The Way Forward?
por: van Griensven, Johan, et al.
Publicado: (2014)

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis
por: Verrest, Luka, et al.
Publicado: (2023)

The Household Costs of Visceral Leishmaniasis Care in South-eastern Nepal
por: Uranw, Surendra, et al.
Publicado: (2013)

Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh—A Case Report
por: Marking, Ulrika, et al.
Publicado: (2014)

Visceral Leishmaniasis, Northern Somalia, 2013–2019
por: Aalto, Mikko K., et al.
Publicado: (2020)

Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
por: Kimutai, Robert, et al.
Publicado: (2017)

Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010
por: Picado, Albert, et al.
Publicado: (2012)

Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans
por: Dahal, Prabin, et al.
Publicado: (2021)

Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial
por: Musa, Ahmed M, et al.
Publicado: (2022)

Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines
por: van Griensven, Johan, et al.
Publicado: (2014)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
por: Boodman, Carl, et al.
Publicado: (2023)

An international qualitative study exploring patients’ experiences of cutaneous leishmaniasis: study set-up and protocol
por: Erber, Astrid Christine, et al.
Publicado: (2018)

Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy—A retrospective analysis
por: Kämink, Suzette, et al.
Publicado: (2021)

Outdoor Residual Insecticide Spraying (ODRS), a New Approach for the Control of the Exophilic Vectors of Human Visceral Leishmaniasis: Phlebotomus orientalis in East Africa
por: Elnaiem, Dia-Eldin A., et al.
Publicado: (2020)

Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, Northern Ethiopia: A qualitative study
por: Coulborn, Rebecca Marie, et al.
Publicado: (2018)

Visceral Leishmaniasis in Rural Bihar, India
por: Hasker, Epco, et al.
Publicado: (2012)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008
por: Malaviya, Paritosh, et al.
Publicado: (2011)

Visceral Leishmaniasis in the Muzaffapur Demographic Surveillance Site: A Spatiotemporal Analysis
por: Hasker, Epco, et al.
Publicado: (2018)

Visceral leishmaniasis in eastern Africa – current status
por: Reithinger, Richard, et al.
Publicado: (2007)

Barriers to cervical cancer screening among rural women in eastern China: a qualitative study
por: Yang, Huan, et al.
Publicado: (2019)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study
por: Abongomera, Charles, et al.
Publicado: (2016)

Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa
por: Palić, Semra, et al.
Publicado: (2020)

A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan
por: Kämink, Suzette S., et al.
Publicado: (2017)

Outcomes of visceral leishmaniasis in pregnancy: A retrospective cohort study from South Sudan
por: Pekelharing, Judith E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3mk8j9imtnr3spli8macvqul40